Catheter Precision, Inc. (NYSE American: VTAK) Secures First Purchase Order for LockeT in Chicago Region

Catheter Precision, Inc. (NYSE American: VTAK), a leader in the MedTech sector specializing in cardiac electrophysiology, has announced its first purchase order from a hospital in the greater Chicago area. This development follows the company's recent expansion of its US sales and clinical teams, gearing up for the nationwide launch of their product, LockeT.

The initial purchase order comes from Endeavor Health System, the third largest healthcare network in Illinois, encompassing nine hospitals and over 7,100 physicians. This marks a significant milestone for Catheter Precision as it bolsters its presence in the US market.

"Since joining Catheter Precision on May 1st, we have established the necessary sales infrastructure to attract new customers in both the US and Europe. This new order is one of many we anticipate in the upcoming months," stated Marie-Claude Jaques, Chief Commercial Officer. "We are excited to introduce LockeT's potential benefits to various healthcare stakeholders."